Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,000
Closed -$205K 124
2026
Q1
$205K Sell
2,000
-75
-4% -$8.47K 0.04% 116
2025
Q4
$260K Buy
2,075
+75
+4% +$9.55K 0.05% 105
2025
Q3
$268K Hold
2,000
0.04% 101
2025
Q2
$272K Sell
2,000
-353
-15% -$46.5K 0.05% 104
2025
Q1
$312K Hold
2,353
0.06% 94
2024
Q4
$266K Sell
2,353
-355
-13% -$41K 0.05% 118
2024
Q3
$309K Hold
2,708
0.06% 117
2024
Q2
$281K Hold
2,708
0.06% 123
2024
Q1
$308K Hold
2,708
0.07% 127
2023
Q4
$298K Sell
2,708
-68
-2% -$6.79K 0.07% 126
2023
Q3
$269K Buy
2,776
+68
+3% +$7.14K 0.07% 137
2023
Q2
$295K Sell
2,708
-353
-12% -$37.6K 0.07% 136
2023
Q1
$310K Hold
3,061
0.08% 155
2022
Q4
$336K Hold
3,061
0.09% 137
2022
Q3
$296K Hold
3,061
0.09% 140
2022
Q2
$333K Hold
3,061
0.09% 144
2022
Q1
$362K Hold
3,061
0.11% 138
2021
Q4
$431K Hold
3,061
0.12% 130
2021
Q3
$362K Hold
3,061
0.11% 151
2021
Q2
$355K Hold
3,061
0.11% 149
2021
Q1
$367K Sell
3,061
-653
-18% -$77.4K 0.11% 135
2020
Q4
$407K Buy
3,714
+1,714
+86% +$186K 0.14% 129
2020
Q3
$218K Buy
+2,000
New +$203K 0.1% 151

Other funds holding ABT

Bellecapital's ABT Position: Q2 2026 in Review

Bellecapital sold out of Abbott (ABT) in Q2 2026, closing a stake of 2,000 shares — an estimated $205K sold.

Bellecapital first reported a position in ABT in Q3 2020 and held it in 23 quarters. The position peaked at $431K in Q4 2021. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Bellecapital reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
  • Bellecapital sold 2,000 Abbott shares in Q2 2026, an estimated $205K.
  • Bellecapital first reported a position in Abbott in Q3 2020 and held it in 23 quarters.
  • Bellecapital's Abbott position peaked at $431K in Q4 2021.
  • 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Bellecapital's 13F filing for Q2 2026, filed 22 Jul 2026.